With Federal Legalization Stalled, Cannabis Companies Are Finding A New Green Rush In Europe

Key Concepts

• Federal legalization stall in the US
• European cannabis market as a new "green rush"
• Medical and recreational cannabis legalization/decriminalization in various European countries
• Cross-border cannabis trade within the EU
• Market size and growth projections for US vs. EU cannabis markets
• Active's expansion into the European market
• Government collaboration and financial incentives in the European cannabis market

Active's Expansion into Europe

• Active, a California-based vaporizer hardware manufacturer, is expanding into the European cannabis market due to stalled federal legalization in the US.
• Alex Quan, co-founder and CEO of Active, began selling THC oil vape tech to cannabis companies in the UK about 2 years ago.
• Active's revenue from European cannabis companies, primarily in the UK and Germany, currently accounts for more than 5% of the company's total revenue.
• Quan is negotiating a deal with an EU brand to further expand Active's European business.
• Quan believes Europe could grow to 20% of Active's sales.
• Active's annual revenue is estimated to be more than $100 million.
• Active sells vaporizers made for oil to some of the biggest cannabis companies in the US including True Leave, Green Thumb Industries, and Cure Leaf.

The European Cannabis Market: A New "Green Rush"

• The EU, where about 25 countries have some form of cannabis legalization or decriminalization, is poised to become a $50 billion annual sales market if reform spreads across the continent, according to Whitney Economics.
• Quan views Europe as the "battleground where cannabis is going to be won" and the "gateway to the rest of the world."
• While the US cannabis market is projected to grow 44% in 3 years (from $32 billion to $46 billion), the EU market is expected to grow 115% over the same period.
• EU businesses can grow cannabis in one country and export products across the continent, unlike US cannabis companies that cannot transport product across state lines.
• The EU cannabis market is currently small, with annual sales expected to reach $1.2 billion this year (according to Prohibition Partners).
• Prohibition Partners projects the EU market to reach $2.6 billion in 2028 and $6 billion within a decade or more, a 400%+ jump from this year.

Country-Specific Market Data

• Germany, the EU's largest economy and legal marijuana industry, had about $500 million in sales last year and is expected to generate just under $1 billion in sales at the end of 2025.
• The UK, which is not part of the EU, has a medical market with about $255 million in annual sales.
• The Netherlands and Switzerland have launched pilot programs to test recreational marijuana.
• Poland, the Czech Republic, and other countries have launched medical programs.
• Malta and Luxembourg currently have adult use programs.
• France has proposed medical legalization measures.

US vs. European Market Comparison

• The US, with 38 states having some form of legalization, generated $32 billion in annual legal cannabis sales last year.
• Europe's cannabis market is currently about the size of New Jersey's marijuana economy.
• Europe offers practical regulations that allow cannabis to be grown in Spain and Portugal and exported to other countries legally, creating a solid investment thesis for US companies.
• Bo Whitney, founder of Whitney Economics, emphasizes that Europe is an emerging market that's too important to ignore.
• While the US had a head start (California legalized medical marijuana in 1996), the European market features government collaboration and financial incentives that the US does not.

Notable Quotes

• Alex Quan: "We started with putting our toe into the European market but now we have a swimsuit on and we're walking in up to our belly soon we will be diving in."
• Alex Quan: "Europe could easily grow to 20% of our sales."
• Alex Quan: "I think Europe is the battleground where cannabis is going to be won it's the gateway to the rest of the world."
• Bo Whitney: Europe is an emerging market that's too important to ignore.

Synthesis/Conclusion

With federal legalization stalled in the US, cannabis companies like Active are turning to the burgeoning European market for growth. The EU's potential for cross-border trade, coupled with government support and financial incentives, makes it an attractive investment opportunity. While the US market is currently larger, the EU market is projected to grow at a faster rate, making it a key battleground for the future of the global cannabis industry. The combination of medical and recreational legalization efforts across various European countries, along with favorable regulations in some regions, is driving significant investment and expansion from US-based cannabis companies.